Filing Details

Accession Number:
0001493152-21-006314
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-18 14:08:34
Reporting Period:
2021-03-16
Accepted Time:
2021-03-18 14:08:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
772320 Gene Biotherapeutics Inc. CRXM Biological Products, (No Disgnostic Substances) (2836) 840635673
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1741021 J Christopher Jemapete 6888 S. Irvington Court
Aurora CO 80016
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-16 300,000 $0.04 3,800,000 No 4 P Direct
Common Stock Acquisiton 2021-03-17 200,000 $0.40 4,000,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Represents the weighted average purchase price for two transactions effected on March 16, 2021, with purchase prices per share ranging from $0.0378 to $0.04. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  2. Represents the weighted average purchase price for 16 transactions effected on March 17, 2021, with purchase prices per share ranging from $0.0378 to $0.0425. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.